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Johne’s disease is of high economic and welfare importance with a cost of £13 
million to the UK cattle industry per year (Bond and Guitian, 2015). In addition, 
it is of zoonotic importance with studies suggesting a causal effect between 
Johne’s disease and Crohn’s disease in humans (Botsaris et al, 2016). Johne’s 
disease is caused by the Mycobacterium avium subsp. paratuberculosis 
(MAP) pathogen which results in a chronic enteric infection (Rue-Albrecht et 
al, 2014). There have been several management strategies applied to the 
control of Johne’s disease including biosecurity measures (NADIS, 2016), herd 
management (SAC, 2003), vaccination (NADIS, 2016 b) and targeted breeding 
(Minozzi et al, 2012). This study investigates the use of the High Immune 
Response (HIR) technology (Mallard et al, 2011) to identify cattle which have 
estimated breeding values (EBVs) capable of promoting resistance to MAP 
pathogens. The researcher completed this research study in vitro, 
macrophages were isolated from the blood of cattle with HIR tested EBV types 
and measured for immune response indicators (nitric oxide (NO) release and 
pH) (Owen, Punt and Stanford, 2013). The results of the laboratory tests were 
analysed using GenStat 18th Edition. Using a confidence level of 0.05 it was 
found that there were no statistically significant differences between the 
immune EBV types for NO release, however as predicted the high cell 
mediated immune response (CMIR) and high antibody mediated immune 
response (AMIR) (HH) macrophages produced more NO than the low (CMIR) 
and low (AMIR) (LL) macrophages. The contrast level of pH release between 
HH and LL macrophages was 0.061 and although not statistically significant 
the results did show that there was a difference between the EBV groups. The 
difference between high AMIR, low CMIR (HL) and low AMIR, high CMIR (LH) 
cattle EBVs, was found to be statistically significant in relation to pH with cattle 
that had a high response for cell mediated immune response reducing pH to a 
lower level and therefore exhibiting a mechanism to destroy MAP pathogens 
in vitro more successfully than the other EBVs. The difference between HH 
and LL macrophage pH release was not found to be statistically significant. It 
is suggested that this study should be repeated with a larger cohort of cattle 
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Johne’s disease is a common endemic disease in the UK. It is a chronic 
enteritis which is caused by the Mycobacterium avium subsp. paratuberculosis  
(MAP) pathogen (Rue-Albrecht et al, 2014). Johne’s disease has been 
estimated to cost £13 million to the UK dairy and beef industries per year (Bond 
and Guitian, 2015) with losses experienced directly from the culling out of 
infected cattle as well as indirectly through a loss of milk yield, veterinary costs, 
a reduction in fertility and increased labour and management (SAC, 2003). 
Johne’s disease also causes problems for cattle welfare, with chronic wasting 
seen during the late phases of disease progression (Arsenault et al, 2014). In 
addition, MAP has been associated with human cases of Crohn’s disease, 
making it of zoonotic importance (Botsaris et al, 2016).  
Approaches to control Johne’s disease include biosecurity measures which 
consist of reducing or stopping cattle movements and vaccination. A licence to 
vaccinate cattle can be applied for in the UK, however the current test 
interferes with the bovine tuberculosis (TB) skin test and can cause false 
negative reactions, meaning that TB infected cattle can go undetected (NADIS, 
2016 b). Research is currently being undertaken to identify specific markers 
within the bovine genome which promote Johne’s resistance, however it has 
been found that multiple loci contribute to resistance due to the complexity of 
the immune response caused by MAP pathogens (Minozzi et al, 2012). 
Research studies into bovine tuberculosis which is caused by a closely related 
pathogen, Mycobacterium bovis have indicated that TB resistance is heritable 
at 9% (AHDB, 2016 c) however, it is argued that breeding for individual traits 
can cause problems for broad based disease resistance due to negative 
genetic correlations (Thompson-Crispi, Miglior and Mallard, 2013). 
The concept of broad based disease resistance is the underlying principle of 
the High Immune Response (HIR) technology. The HIR technology enables 
breeders to identify cattle as high (HIR), medium (MIR) or low (LIR) responders 
with research showing that HIR cattle have less cases of several diseases of 
both economic and welfare importance including mastitis, metritis, ketosis, 
retained placenta and displaced abomasum as well as preliminary evidence 
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showing that HIR cattle are less likely to test positive for Johne’s disease 
(Mallard et al, 2014). The heritability of the HIR trait in cattle is ~30% (Semex, 
2015). 
The HIR test is based on a measurement of the adaptive immune response. 
Adaptive immune response in cattle works in two ways, through antibody 
mediated immune response (AMIR) which generally protects the body from 
extracellular pathogens such as mastitis (Thompson- Crispi et al, 2012) and 
cell mediated immune response (CMIR) which wards off intracellular 
pathogens (Nicholas, 1996) such as those presented in Johne’s infection 
(Arsenault et al, 2014). Research has shown that these immune responses are 
both required at a high level in order to promote broad based disease 
resistance although in cattle are often genetically negatively correlated 
(Thompson-Crispi, Miglior and Mallard, 2013).  
As stated above, Johne’s disease is predominantly mediated by a CMIR 
although research indicates that if the CMIR is not strong enough or the 
pathogen is able to evade the hosts defence mechanisms, a non-protective 
AMIR will take over which can lead to dissemination of the pathogen 
(Magombedze, Eda and Ganusov, 2014).  
This research study investigated if cattle with different immune response 
estimated breeding values (EBVs) as determined by the HIR technology were 
more or less likely to promote disease resistance to MAP pathogens. In order 
to measure immune response macrophages were isolated from blood and 
challenged in vitro with whole cell deactivated MAP and two recombinant 
proteins from MAP. Nitric Oxide (NO) and pH were measured, both indicators 
of an immune response towards MAP pathogens (Arsenault et al, 2014). 
The researcher hypothesised that based on current HIR research, cattle with 
EBVs for high AMIR and high CMIR (HH) would produce higher NO 
concentrations than cattle with EBVs for low AMIR and low CMIR (LL). The 
production of a higher concentration of NO in cattle with HH EBVs was 
hypothesised as a result of the immune reaction to eliminate the pathogen as 
well as dropping the pH to a lower acidity, an indicator of phagolysosomal 
fusion and subsequent elimination of the pathogen (Rue-Albrecht et al, 2014). 
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It was also hypothesised that cattle with low AMIR and high CMIR (LH) would 
produce a stronger immune response than cattle with high AMIR and low CMIR 
(HL) due to the MAP pathogen being intracellular and requiring a high cellular 
response to destroy it. The null hypothesis stated that all EBV’s would produce 
the same reaction. 
The results of the experiment were analysed using Genstat 18 th Edition. A 
confidence level of 0.05 was applied to an Analysis of Variance (ANOVA) test, 
with contrasts applied between the EBV groups. There were no statistically 
significant results found between the EBV groups for NO release, however as 
predicted the HH macrophages produced a higher concentration of NO than 
the LL macrophages. Contrast testing between the EBV groups for pH release 
found a statistically significant result between the HL and LH macrophages 
with the LH EBV (high CMIR) dropping the intracellular pH significantly and 
therefore exhibiting a mechanism to destroy MAP pathogens in vitro more 
successfully than the other EBVs. The difference between HH and LL 
macrophage pH release was not found to be statistically significant. The cohort 
of cattle tested was small and it is therefore concluded that further research 
into the area should be completed with larger cohorts before the alternate 









2.  Literature Review 
2.1 UK Dairy industry 
The size of the dairy industry in the United Kingdom has fallen dramatically 
over the past 20 years with a recorded 35,741 dairy farms in 1995 dropping to 
13,815 by 2014 (Bate, 2016). However, despite a drop in dairy farming 
enterprises, herd numbers have recently been rising with a 5.9% increase in 
the UK average herd size between 2013 and 2014. In 1996, the average herd 
size stood at 78 cows, whereas statistics from 2014 show an average herd 
size of 136 (AHDB, Dairy, 2015a).  
In addition to an increase in herd size, average milk yield rose by 373 litres per 
cow from 2013 to 2014 (AHDB Dairy, 2015b). This indicates that although the 
size of the dairy industry has contracted, the expectation for increased 
production from the dairy cow has increased with a recorded 93% growth in 
yield, per cow since 1975 (Bate, 2016). 
An FAO (2015) report stated that world cow milk production stood at 636 
million litres in 2013 with the largest producer being the United States of 
America. Production in the US has been predicted at 96.3 million tonnes for 
2015. 
2.2 Dairy industry trends 
The UK is currently the third-largest milk producer in Europe and the tenth 
largest producer globally (Bate, 2016). Low milk prices however, have become 
an increasing issue globally; this is due to an uneven supply demand factor. 
Milk production has been growing 5% on average per year; however global 
demand for milk is only rising by 2% on average, leading to a rise in global 
stocks and therefore a reduction in pence per litre received by farmers 
(Parliament UK, 2015). In August 2015, farm-gate milk prices dropped to 23.3 
pence per litre, the lowest recorded monthly figure since 2009 (Bate, 2016).  
Despite negative economic trends in the dairy industry, the food industry as a 
whole is growing, with the world’s population expected to increase to 9 billion 
by 2050 (World Bank, 2015). According to the World Bank (2015), cereal and 
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meat production will need to increase by 50% in order to feed the global 
population in 2050 and with this, dairy sales are also predicted to increase. In 
order for the dairy industry to meet future demands and to ensure economic 
stability it is important that on farm husbandry costs are reduced. One major 
cost implication to the dairy industry is the cost of disease. There are over 1.3 
billion cattle globally and therefore the economics of disease incidence on a 
global scale is difficult to estimate (Meade, 2015) however, Casey et al (2015) 
indicate that the cost of infectious disease1 breakdown in the US is between 
$200 million and $150 billion per year with cost rising accordingly with the 
increasing prevalence of disease. 
2.3 Disease in dairy cattle 
As previously mentioned, one factor which has a major implication for the 
economics of the dairy industry is disease. There are many dairy cattle 
diseases in the UK, with variations of severity in terms of cost as well as the 
differing impact on animal welfare and risk to human populations (AHDB Dairy, 
2015c).  
According to Compassion In World Farming (2010) the most common 
diseases in dairy cattle are mastitis, lameness (most commonly white line 
disease (AHDB Dairy, 2016)), metabolic diseases such as ketosis, acidosis 
hypocalcaemia (milk fever) and hypomagnesaemia (grass staggers) as well 
as fertility related diseases such as endometritis/ metritis.  
In addition to the diseases above, the most common endemic infectious 
diseases to the UK include; bovine viral diarrhoea (BVD) which costs the UK 
farming industry £50- £75 million per year (XL Vets, 2011), infectious bovine 
rhinotracheitis (IBR)2 and bovine tuberculosis which has cost the UK taxpayer 
~£500 million between 2004 and 2014 and has an average on farm breakdown 
cost of £34,000 (TB Free England, 2014). Johne’s disease also represents one 
of the most common endemic infectious diseases in the UK and is the focus of 
                                                          
1 Infectious disease examples include; Johne’s Disease, Neospora, Leptospirosis, Bovine Virus 
Diarrhoea, Infectious Bovine Rhinotracheitis (NADIS, 2015) 
2 An exact cost for IBR could not be found, however, calf pneumonia has an annual cost of £80 
million to the UK farming economy. Calf pneumonia includes viruses such as IBR, RSV and Pi3 as 
well as bacteria pathogens such as mycoplasma bovis, pastuerella, mannheimia and 
haemophilus (XL Vets, 2015) 
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this research study. The diseases mentioned above all have serious welfare 
implications for the animal as well as having high economic consequences for 
the farmer (Gov.UK, 2012). 
2.4 Johne’s Disease 
2.4.1 Overview and economics 
Johne’s disease, as previously mentioned, is a common endemic disease in 
the UK. It is a mycobacterial infection caused by the Mycobacterium avium 
subspecies. paratuberculosis (MAP) pathogen. Mycobacterium is a gram-
positive genus of bacteria with over 120 species. Most mycobacteria species 
are non-pathogenic environmental bacteria; however a few sub-species have 
evolved highly effective intracellular mechanisms resulting in chronic infection 
and high morbidity and mortality rates. There are two major mycobacterium 
species that affect the dairy industry; these are MAP and Mycobacterium bovis, 
which causes bovine tuberculosis in cattle (Rue-Albrecht, et al 2014).  
According to Bond and Guitian (2015) the cost of Johne’s disease in the UK is 
£13 million annually (beef and dairy industry). The cost of the disease to 
individual farms in the UK dairy industry however, is highly variable and is 
dependent on management strategies and the testing regimes put in place by 
the famer and their vet. As a direct result of the disease animals will be culled 
out of the herd resulting in the loss of the infected animal. There are also a 
number of hidden costs associated with Johne’s disease infection which 
include; production loss, a reduction in fertility, veterinary treatment, increased 
farm labour and management, replacement cost and the market value of the 
herd reduced (Scottish Agricultural College, 2003). The University of Reading 
(2015) have developed a financial model in order to determine the cost of a 
Johne’s breakdown at farm level. Although this figure would vary farm to farm 
with different systems and environmental pressures, the calculation below can 
be used as a good indicator of a farm level scenario in the UK.   
If a Johne’s disease-free dairy herd with 150 cows in milk introduced 10 low-
shedding carriers without using any test/control measures, the average cost in 
losses would equate to £17,000 per year over the following 10 years (£170,000 
total loss). If management and control strategies were put in place, this cost 
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would reduce to £3100 per year on average (over 10 years, £31,000) 
(University of Reading, 2015).  
According to Rue-Albrecht et al (2014), Johne’s represents an estimated loss 
of $250 million to the US dairy industry annually with average herd prevalence 
in some US states (as well as some European countries) being greater than 
50%. 
2.4.2 Zoonotic importance 
In addition to the cost of Johne’s disease to the farming industry, the disease 
is also of potential zoonotic importance.  A recent study carried out an analysis 
of viable MAP pathogens in pasteurised infant formulas, through the use of a 
phage-PCR assay it was found that of 32 samples, 4 samples contained viable 
MAP pathogens (12.5%) with 3 of the 4 samples being culture detected. 
Previous studies found that approximately 2% of pasteurised milk samples 
contained viable MAP pathogens (Botsaris et al, 2016). These findings are a 
matter of public health concern due to the associations between MAP and 
human Crohn’s disease/ Inflammatory Bowel Disease (IBD). In 1913 the first 
associations where made between Johne’s and Crohn’s disease and although 
a causal link between the two has not yet been defined (Atreya et al, 2014) it 
has been shown that there is a positive association between the exposure of 
humans to MAP and Crohn’s disease (Botsaris et al, 2016). 
2.4.3 Johnes disease presentation  
Johne’s disease affects all ruminants with beef and dairy cattle being a major 
host. It is a chronic inflammatory disease of the gastrointestinal tract with four 
stages of disease progression: silent, subclinical, clinical and advanced 
infection. Tissue and regional lymph nodes of the gastrointestinal tract become 
inflamed following the hosts immune response mechanisms, this inflammation 
effectively results in reducing the host’s ability to absorb nutrients and clinical 
disease presentation can therefore be seen with signs of wasting due to 
significant weight loss and diarrhoea (Rue-Albrecht et al, 2014). During 
systemic clinical infection the pathogen can also be detected in milk (Botsaris 
et al, 2016).  
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The disease is difficult to diagnose due to the silent infection phase coupled 
with a prolonged subclinical phase of around three to five years. Upon clinical 
disease presentation the disease can be detected through the use of a blood 
antibody test (ELISA), however this method isn’t fully effective until the late 
stages of the disease, when an antibody mediated response becomes 
predominant (Animal Health and Welfare NI, 2014). MAP pathogens can also 
be detected through collection of faeces and subsequent laboratory culture; 
however this method is often ineffective in animals under the age of two due 
to insufficient bacterial load within the faeces. Due to the inefficiency of the two 
aforementioned detection methods disease classification is often not accurate 
until a post-mortem following death (SAC, 2003). 
2.4.4 Modes of transmission  
Johne’s disease infection most commonly occurs in the neonatal period 
through the vertical transmission route (dam to offspring) (Arsenault et al, 
2014). The pathogen has the ability to pass through the placenta into the foetus 
with one study concluding that 9% of calves from sub-clinically infected dams 
and 39% of calves from clinically infected dams were infected in utero with 
MAP (Behr and Collins, 2010). More commonly however, neonates are 
infected through the oral route following colostrum intake which has been 
shown to harbour a high pathogen load (Chai-Wei Wu et al, 2007). In addition 
to infection routes described above, calves can become infected through 
horizontal transmission. This can be through exposure to pathogens on dirty 
teats, which if the environmental pathogen burden is high may or may not be 
contracted directly from the dam (SAC, 2003). Other horizontal infection routes 
include oral intake of contaminated soil or through bodily fluids such as saliva 
(vertically through the dam or horizontally through other infected cattle/wildlife 
hosts), semen or uterine fluid on dirty bedding (Arsenault et al, 2014). 
Pooled colostrum has been reported to increase disease transfer and is often 
advised against in Johne’s control programmes. A study by Nielsen, Bjerre and 
Toft (2008) found that calves fed from a pooled colostrum tank had a higher 
probability of testing positive with an antibody test. In addition, the researchers 
found that pooled milk from cows with a high somatic cell count (which is 
deemed unfit for human consumption) also increased the likelihood of a 
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positive antibody test with the conclusion that pooled colostrum increased the 
chance of viable MAP pathogens being fed to calves. 
Disease susceptibility reduces over the first year of a calf’s life with the risk of 
transmission and subsequent infection being highest within the first few 
months of life. At one year of age a calf is expected to have the same level of 
disease tolerance as an adult cow with the level of MAP pathogens required 
to cause disease being much higher as well as a longer exposure period being 
required (Arsenault et al, 2014). 
NADIS (2016), state that Johne’s disease can be introduced to farms in a 
number of ways including the introduction of new stock which could be either  
clinically diseased or sub-clinically incubating the disease as well as through 
the introduction of animals that appear healthy but are in fact carriers. It is also 
possible that the pathogen could be introduced through the transportation of 
infected faeces from an infected farm to a clean farm via vehicles, equipment 
or on the clothing or footwear of people. It is therefore important that 
biosecurity measures are undertaken on farms in order to minimise the risk of 
cattle being exposed to the pathogen. Good biosecurity measures are based 
on four key principles and include the selection of all necessary purchased 
animals from herds which have a known herd health status, isolate animals 
following purchase and before introduction to the rest of the herd, control 
movements on and off of farm including vehicles, animals and people and 
finally facilitate good sanitation practices to ensure that all people and 
equipment entering the farm is properly disinfected.  
2.5 Overview of the immune response system3 
The immune system is responsible for recognising, resisting and eliminating 
health challenges which may be issued from a broad range of infectious 
organisms (Cooke, 2010). It is therefore important, in order to control infectious 
diseases such as Johne’s disease in the dairy industry effectively that the 
immune response of dairy cattle is understood (Meade, 2015). It has been 
documented in the literature that disease prevalence on individual farms as 
well as within the national and global herd is dependent on immune response 
                                                          
3 Cells of the immune system can be found in Appendix A 
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with a good herd health status being fundamental for optimal performance 
(Cooke, 2010).  
The immune system of livestock species is generally based on two immune 
responses, innate and adaptive, although these systems are not independent 
of each other and there is a high proportion of cross over between the two 
response types (Owen, Punt and Stranford, 2013 pp.173-174) they will be 
discussed separately.  
2.5.1 Innate Immunity  
The innate immune response is immediate, non-specific and does not confer 
a long-lasting protection. It is activated upon host recognition of a foreign 
pathogen via the innate defence barriers including the epithelium 
(skin/feathers) and mucous membranes (Murphy, 2012 pp.37-40). The innate 
response also involves cells which are present in the adaptive immune system 
and includes phagocytic leukocytes, macrophages and Natural Killer (NK) 
cells, which act to destroy and remove invading pathogens (Owen, Punt and 
Stranford, 2013 pp. 168-169). 
Invading pathogens will commonly be met by a macrophage (Brooks et al, 
2013 p.125). Macrophages have microbial sensors which include toll-like 
receptors (TLRs), Nucleotide-binding Oligomerization Domain- like receptors 
(NLRs) and Retinoic acid-Inducible Gene 1 (RIG-1) like helicases and 
Melanoma Differentiation-Associated protein 5 (MDA-5). As described above, 
the key elements of the innate immune response include rapidity, non-
specificity and short duration. These elements are all also features of the 
phagocytic process which the macrophage carries out (Murphy, 2012 pp.76-
80). Phagocytosis is the process in which an invading pathogen is recognised 
by the macrophages microbial sensors and then upon confirmation that it is a 
foreign body engulfed by the immune cell. Once the pathogen is engulfed by 
a macrophage it is internalised into an endocytic vesicle called the 
phagosome, here it is subject to antimicrobial mechanisms designed to kill the 
pathogen, for example, the phagosome lyses with the cell lysosome in order 
to create the phagolysosome which has a highly acidic pH in order to destroy 
the invading pathogen. In addition, toxic reactive nitrogen and oxygen species 
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are produced and nitric oxide (NO) is formed which also helps to destroy 
pathogens (Owen, Punt and Stranford, 2013 pp. 147-151). In addition to the 
internal activities of macrophages, the cells also release cytokines and 
chemokines which initiate the process of inflammation. Phagocytosis and 
inflammation processes may also be activated by the complement system, a 
collection of proteins which work to activate a cascade of proteolytic reactions 
on invading cell surfaces. The complement system coats pathogens with 
fragments which are recognised by the phagocytic receptors on macrophages, 
offering an alternative pathway for pathogen destruction. The process of 
phagocytosis and the complement system are processes which cross over 
with the adaptive immune system and both function after the innate response 
has concluded (Janeway et al, 2005 pp.12-13). 
If the pathogen challenge cannot be successfully removed by the innate 
immune response the adaptive response is activated (over a period of 4-7 
days) (Owen, Punt and Stranford, 2013 p.12). This transition is primarily 
mediated by cells such as macrophages (and other white blood cells) as well 
as the complement system, which introduce the foreign agent to specific cells 
in the adaptive immune response as well as activating cells involved in the 
adaptive immune response (Cooke, 2010). 
2.5.2 Adaptive Immunity 
The adaptive immune response is highly specific, has memory and can 
therefore respond rapidly to a repeated antigen exposure. The adaptive 
immune response is further split into two types; antibody mediated immune 
response (AMIR) and cell mediated immune response (CMIR), although these 
responses are not independent of each other (Brooks et al, 2013 pp.127-128) 
research has shown that they can be negatively genetically correlated 
(Thompson- Crispi et al, 2012). An adaptive immune response is characterised 
by the production of antibodies from activated B cells and activities of T-cells 
(Cooke, 2010). 
2.5.2.1 Antibody Mediated Immune Response 
A protective antibody response is derived from lymphoid progenitor cells which 
have evolved into B cells, these cells can be found in the blood and are 
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developed in the bone marrow of cattle, as depicted in Figure 1 below. AMIR  
is activated by helper T-lymphoctes (Cluster of Differentiation 4 (CD4)) which 
recognise major histocompatibility complex class4 (MHC) II antigen 
presentation on the surface of antigen presenting cells such as macrophages 
and then produce cytokines which activate B cells that express the antigen 
which matches the antigen being presented. Following the activation of B cells 
they undergo clonal proliferation in order to produce specific antibodies to 
combat the pathogen through a process of agglutination, precipitation and 
eventually cell death as well as creating memory B-cells5 which are stored in 
the body ready to respond rapidly following a second exposure to the specific 
antigen (Brooks et al, 2013 pp.127-128).  
Figure 1: Antibody Mediated Immune Response Illustration  
 
As mentioned in the description of the innate immune system in section 2.5.1, 
phagocytosis is also a part of the adaptive immune response. Pathogens 
which have been bound by antibody are delivered to phagocytic cells for 
ingestion, degradation and removal from the body. The complement system 
which also crosses over from the innate immune response, works alongside 
antibodies in the adaptive immune response in order to enhance bactericidal 
                                                          
4 The Major Histocompatibility Complex (MHC) plays a major role in binding peptides from 
pathogens and presenting them to the cell surface as an antigen which is then recognised by 
receptor T cells. MHC in AMIR and CMIR are different, in antibody response MHC presentation 
of an antigen results in antibody production whereas in CMIR MHC antigen presentation 
results in the activation of cytotoxic T cells which are directly responsible for destroying 
pathogens (Owen, Punt and Stranford, 2013 pp.262-271) 
5 Memory B- cells make vaccination possible 
Some materials have been removed due to 3rd party copyright. The unabridged 




The constant region takes one of four biochemically forms whereas the 
variable region can be composed of an apparent infinite number of forms 6 
which enables the antibody to bind with an equally diverse number of antigens. 
As illustrated in Figure 2, each antibody molecule has a two-fold axis of 
symmetry and is composed of two identical heavy chains as well as two 
identical light chains. Antigen binding sites are composed of a heavy and a 
light chain, meaning that both chains contribute to binding specificity however 
it is the constant region that determines how the antigen will be destroyed. 
(Janeway et al, 2005 pp.17-18).  
According to Thompson- Crispi et al (2012), extracellular pathogens such as 
extracellular bacteria, extracellular protozoan, parasites and helminthic worms 
are generally combated by an AMIR. 
2.5.2.2 Cell Mediated Immune Response 
Whist AMIR generally defends the host from extracellular pathogens, CMIR 
protects against intracellular pathogens such as viruses, intracellular bacteria 
and protozoa (Mogensen, 2009). Pathogens are only accessible to antibodies 
in the blood (extracellularly), however a range of pathogens including some 
bacterial and parasitic pathogens as well as all viruses replicate inside host 
cells where they cannot be seen by antibodies. T lympohcytes or T-cells are 
the cells responsible for CMIR (Janeway et al, 2005 p.26-27). The cell 
mediated response is activated through recognition of the antigen-MHC class 
II by helper (CD4+) T lymphocytes as well as the recognition of the antigen-
MHC class I complex by cytotoxic (CD8+) T lymphocytes7 on antigen 
presenting cells such as macrophages8. As with AMIR following activation, T 
cells produce cytokines and expand by clonal proliferation (Owen, Punt and 
Stranford, 2013 p.427-432). CD4+ cells stimulate B cells to produce antibodies 
which help with intracellular bacterial infection control from pathogens such as 
Mycobacterium avium subspecies paratuberculosis  (Brooks et al, 2013 p.128) 
the pathogen of interest for this research study. CD8+ cells are primarily 
                                                          
6 High variability is generated through random recombination of variable sector gene segments 
(DNA), this enables the production of antibodies that have the ability to recognise virtually any 
antigen  
7 CMIR can be measured through IFN-y release 
8 IFN-y release stimulates the macrophage to express the MAP antigen on its surface (Casey 
et al, 2015) 
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involved with the destruction of tumour cells, cells in tissue grafts or cells 
infected by viruses (Murphy, 2012 pp.369-374). 
The adaptive immune response can be enhanced through breeding practices 
and forms the basis of the High Immune Response technology which will be 
discussed in Section 2.8. 
2.5.3 Immunological mechanisms specific to Johne’s Disease 
Following ingestion of MAP, the ruminant digestive system activates the 
bacterial cell wall protein fibronectin attachment protein (FAP) in order to 
promote opsonisation by fibronectin (Arsenault et al, 2014). The intestinal 
epithelium is the largest surface area in the mammalian body and acts as a 
barrier against commensal and pathogenic bacteria, fibronectin links MAP to 
the luminal surface of intestinal microfold cells through fibronectin receptors. 
MAP pathogens must overcome mucus secretions, antimicrobial peptides, 
secretory IgA, tight junctions and the galcocalyx in order to establish 
themselves within the host (Lamont et al, 2012; Janeway et al, 2005 pp.40-
41). 
Following successful passage through the intestinal epithelium the secondary 
defence mechanisms of the host are activated. As described in section 2.4.5, 
the innate immune system is the body’s first line of defence against invading 
MAP pathogens with the macrophage being the primary phagocytic cell to try 
and eliminate the MAP pathogen (Owen, Punt and Stanford, 2013, pp. 141-
157).  
Once MAP pathogens have been ingested they colonise the mucosa-
associated lymphoid tissues of the upper gastrointestinal tract where they are 
endocytosed through the Peyers patch (Brooks et al, 2013). Macrophages 
specifically are able to see the invading pathogen through the interaction of 
mycobacterial pathogen-associated molecular patterns (PAMPs) which are 
displayed on the surface of MAP bacilli with pathogen recognition receptors 
(PPRs) such as toll like receptors (TLRs) which are displayed on the surface 
of host macrophages (Murphy, 2012, pp. 50-54; Casey et al, 2015). Sub-
epithelial and intraepithelial intestinal macrophages work to phagocytose 
invading MAP pathogens following endocytosis through the Peyers patch. As 
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described in section 2.4.5 the phagosome9 creates an antimicrobial 
environment which is designed to kill the invading pathogen so that it can be 
eliminated from the body (Janeway et al, 2005 pp.42-43).  
Once the phagolysosome has been formed nitric oxide is recruited to kill the 
mycobacterium. A study that investigated mouse macrophages found that 
nitric oxide is directly related to the ability to kill a range of mycobacteria 
species including MAP, Mycobacterium tuberculosis and Mycobacterium 
leprae. In addition, it was found that the inhibition of nitric oxide enabled 
intracellular survival of Mycobacterium tuberculosis in the mouse model 
(Arsenault et al, 2014). Although it has been suggested that the quantitates of 
nitric oxide produced by bovine macrophages are insufficient to completely 
destroy MAP, the fact that MAP pathogens aim to inhibit nitric oxide release 
suggests that the immune mechanism presents a threat to the survival of MAP 
at an intracellular level (Davis et al, 2007). 
Following the activation of macrophage PPRs, signalling pathways are 
activated leading to the production of cytokines and chemokines which lead to 
the activation of the adaptive immune response and promote CMIR (TH1) 
(Brooks et al, 2013). The ability of the host to mount a successful CMIR is 
highly dependent on the individual’s immune system as well as the rate of 
exposure (Rue-Albrecht et al, 2014). 
                                                          
9 Phagosome properties include; acidification, which drops the pH of the environment 
significantly (3.5- 4.0), toxicity, which generates toxic oxygen products, and antimicrobial 




According to Rue-Albrecht et al, (2012) MAP has the ability to evade the CMIR 
of the host effectively by preventing phagolysosomal fusion. This inhibits 
macrophage apoptosis and suppresses the antigen presentation signalling 
mechanisms of the macrophage. In addition to inducing cytokine induced 
necrosis which is essential for the control of the infection (Coussens, 2004), T-
cell interactions10 are also prevented. Clinical infection develops in the 10-15% 
(Arsenault et al, 2014) of cattle that cannot clear the infection with a shift from 
a CMIR to a non-protective AMIR being seen during the late sub-clinical phase. 
CMIR and AMIR can therefore exist simultaneously and it is possible for MAP 
infection to latently infect the host if the animal becomes immune-
compromised due to its ability to reside in macrophages after the CMIR has 
changed to an AMIR (Casey et al, 2015) which is characterised by the 
production of immunolglobin G1 (IgG1) antibodies (Coussens, 2004). Upon 
clinical infection, immunopathology enables the infection to be disseminated 
within the host, eventually leading to bacterial shedding from the animal 
(Casey et al, 2015; Rue-Albrecht et al, 2012; Lamont et al, 2012; Kuehnel et 
al, 2001).  
It is due to this long incubation stage and the ability of MAP to reside in 
macrophages that enables a high infection rate. 
2.5.4 Johne’s Disease Immunological Research 
Due to the economic and welfare issues outlined earlier in this study, research 
has been completed in order to find solutions to the problem of MAP infection 
and Johne’s disease. One of the key attributes of the adaptive immune system 
is that it can be manipulated in order to promote a response which will provide 
long lasting protection. In 1796, Edward Jenner developed the first commercial 
vaccination against smallpox. The concept of vaccination at this time was to 
infect the a human patient with a small amount of dried pathogen from a bovine 
host  in order to stimulate the immune system to produce antibodies for future 
infectious challenge (Janeway et al, 2005 p.642-657).  
                                                          
10 T-cell reactions are characterised by a release of pro inflammatory cytokines such as IFN-
Y, interleukin-1α, interleukin-6 and the production of interleukin-2 (Coussens, 2004) 
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A vaccine against Johne’s disease has been developed for cattle. The vaccine 
is inactivated and permitted for use in the UK under licence. It should be 
administered to calves under one month old (ideally less than a week of age) 
in the brisket area. Use of the vaccine has demonstrated fewer clinical cases 
and losses however, it does not have the ability to completely reduce Johne’s 
disease with faecal shedding and subsequent cases in the herd still occurring. 
A significant problem with vaccinating against Johne’s disease in the UK is that 
it interferes with the current test for bovine tuberculosis (TB) which is 
compulsory under Government policy. The TB test measures immune 
response to Mycobacterium antigens in order to determine if the animal has 
been exposed to Mycobacterium bovis, the test currently uses the MAP 
antigen to measure immune response and therefore if the animal has 
previously been vaccinated against Johne’s disease it is likely that a false 
negative result will occur. This will result in cattle that have been infected with 
TB going undetected, posing a threat to the TB eradication strategy in the UK 
(NADIS, 2016 b).  
In addition to the vaccination control method, researchers have also 
investigated individual resistance to Johne’s disease in order to identify cattle 
that are less susceptible to Johne’s disease. Several studies have identified 
genes for MAP resistance and therefore marker assisted breeding for natural 
immunity towards Johne’s disease has been a popular concept amongst 
researchers (Hinger, Brandt and Erhardt, 2008). Despite gene identification 
the heritability of MAP resistance is very low. An early study in 2000 found that 
MAP resistance was heritable at 0.08 (Koets et al, 2000), this has been 
improved by increased sire daughter records with Mortensen et al (2004) and 
Gonda et al (2006) both reporting heritability at 0.10. Hinger, Brandt and 
Erhardt (2008) reported that heritability ranged between 0.05 and 0.13 
depending on daughter data from sires. It is noted that even with the provision 
of daughter data, the heritability rate for MAP resistance as a single trait is very 
low and therefore both vaccine use and genetic enhancement of specific MAP 




2.6 Breeding  
2.6.1 A historical perspective 
The domestication of cattle began 8000- 10,000 years ago with breeding 
techniques based on cattle characteristics such as; lack of aggression, size 
and the ability to consume unconventional feed. Cattle breeding took off in the 
industrial revolution with an increased demand for meat and milk. Breeding 
became systematic and traits such as milk production led to dairy cattle being 
distinguished from beef cattle. Between 1750 and 1880 there was a period of 
agricultural revolution which led to a rapid increase in the development of cattle 
breeds with new technologies such as milking machines increasing the viability 
of certain traits in dairy cattle. Through new technologies, traits began to be 
bred for more selectively with teat size and ability for milking as well as the size 
of the cow to fit into milking parlours being routinely selected. Breeding was 
further helped by the development of artificial insemination methods in 1899 
which ensured that cattle breeders could select specific traits from bulls across 
the country in order to gain the highest potential from their offspring. The 20 th 
Century brought the classification of the Holstein-Friesian which was 
selectively bred for size in order to reduce labour requirements and therefore 
increase the profit of dairy farmers (Phillips, 2010, pp.50-56).  
2.6.2 Genetics 
The structure of Deoxyribonucleic Acid (DNA) was discovered in 1953 by 
James Watson and Francis Crick. Not only did this lead to key developments 
in medicine but it also enabled scientists to understand the body systems in a 
range of species, including cattle. This fundamental finding led to the ability to 
breed cattle based on their genetic potential and specific traits can therefore 
be bred for as opposed to the phenotypic observations that farmers would have 
made in the past (Phillips, 2010, pp.55-59). 
A key advance in genetic improvement was the introduction of estimated 
breeding values (EBVs) which enabled farmers and breeders to predict the 
offspring performance of animals they wanted to selectively breed from. An 
animal’s breeding value is essentially its genetic merit, half of which will be 
passed to its progeny (Agricultural Business Research Institute, 2016). EBVs 
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incorporate the individual’s performance records as well as their parent’s data 
which can then be benchmarked against breed performance data (Weigel, 
2010). The accuracy of EBVs can vary and are dependent on the available 
data for the trait being measured, for example, bulls with a high number of 
daughters have higher EBV accuracy than those bulls with fewer proven 
daughters (ABRI, 2016). It is important to remember that EBVs can only be 
predicted and are based solely on genetic potential. The environment and 
management system that the offspring is reared in will have a significant 
impact on the true performance of the animal.   
In addition to the accuracy of EBV traits, the heritability of traits can also be 
determined and is the term used to describe how certain characteristics are 
transferred from the sire/dam to their progeny (The Beef Site, 2011). 
Heritability can be described as the proportion of variation observed in a trait 
which is due to genetics (Mallard et al, 2014). The strength of heritability varies 
with each trait, for example, daughter fertility is heritable at 4-7% and longevity 
at 8-10% (Semex, 2012), the higher the percentage value of heritability the 
faster genetic improvement will take place and the positive benefits observed 
in the herd. 
Predicted Transmitting Ability (PTA) is another method which is used to 
improve breeding and measures the relative production potential which will be 
transmitted to the offspring with sires generally selected on the basis of having 
a PTA greater than 70% in order to gain genetic improvement within the herd 
(Andrews, 2014 p.60). 
In addition to PTA, the dairy industry also uses the Profitable Lifetime Index 
(£PLI). £PLI is a within breed genetic index and was developed by AHDB Dairy 
in order to fit with its vision in the UK to breed for dairy cows which have the 
ability to thrive in a number of different farming systems in the country as well 
as giving farmers the opportunity to improve their herd traits (Cattle Health And 
Welfare Group, 2014). 
 £PLI value indicates the additional profit a bull with high £PLI is expected to 
return from each of its daughters over her milking lifetime in comparison to a 
bull ranked as an average £0 PLI. Bulls can be selected from AHDB Dairy’s 
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database, where they are ranked in terms of their traits and can therefore be 
selected in order for the farmer to gain economic potential. Cows and heifers 
also have £PLI indices and it is important that for genetic gain to be 
experienced, the £PLI of the bull is always greater than the £PLI of the dam. 
As mentioned above, the index encompasses traits which have been a focus 
of the national breeding strategy for the past 10 years and include cow health, 
welfare and longevity. The current national breeding goal is ‘f itness’, a trait 
which currently outweighs production in a ratio of 32:68. AHDB Dairy have 
recently moved away from the economical/profit focused traits such as yield 
that £PLI initially worked towards and are instead encouraging the index to be 
used to promote the health and welfare of cattle which in turn will improve the 
productivity of the national herd (AHDB Dairy, 2016b; CHAWG, 2014). In 
addition to ‘fitness’, specific production traits included in £PLI rankings include: 
locomotion, udder composition, fertility and Somatic Cell Count (SCC).  
The introduction of genomics into the dairy industry has enabled breeders to 
measure individual animal DNA in order to determine the form, production and 
health that the specific animal will achieve within its life (given that the correct 
management and environment is provided). In 2006, the Bovine Genome 
Sequencing Project was completed (Canadian Dairy Network, 2009) which 
allowed individual genomic analysis of animals through the examination of 
single nucleotide polymorphisms (SNPs) which use makers to detect 
mutations of single base changes (A,T,C and G) in the DNA structure. The 
sequencing of the bovine genome alongside the ability to detect SNPs has 
enabled livestock scientists to identify important traits such as milk yield 
(Womack, 2009). A high throughput tool has been developed in order to track 
genetic differences on the chromosomes using SNP’s (Winters, 2014). It is due 
to the development of this latest technology that health traits can be observed 
through the identification of quantitative trait loci (QTL) (EC, 2003). 
Current technology includes a new SNP-chip assay which has the ability to 
identify more than 800,000 SNP’s in dairy cattle and therefore cattle can now 
be genotyped in an efficient automated manner leading to increased accuracy 
in breeding as well as a reduction in the generation interval as animals can be 
tested at birth for genetic merit as opposed to previous methods which took 
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five years for bulls to provide sufficient EBV data based on their progeny 
(DairyCo, 2010b). 
With regards to breeding for health, genomic processes have enabled a 
greater understanding of host response to infection and differing response 
types to infection and pathogenic load which has in turn enabled scientists to 
understand individual genetic variation towards disease resistance (Bishop et 
al, 2010, pp.6-8). 
2.7 Breeding for disease resistance 
As discussed above it is possible for breeders to advance production and 
profitability in dairy systems through the use of EBVs, PTAs, £PLIs and more 
recently SNP technology through the selection of traits which are desirable to 
the specific management system. According to Bishop et al (2010, pp.4-5), 
there is evidence for host genetic variation for more than fifty diseases 
throughout the major livestock species. This covers a range of parasites and 
pathogens as well as the genetic resistance of the host ranging from single 
major genes to polygenic gene collaboration (Bishop et al, 2010, pp.4-5). 
Despite the possibility to breed selectively against disease, some genes 
associated with resistance to a specific disease, such as the Johne’s disease 
resistance gene outlined in section 2.4.7 only provide low heritability estimates, 
meaning that genetic gain could only be achieved over many generations 
(Hinger, Brandt and Erhardt, 2008). 
2.7.1 Genetic variation to disease 
As previously discussed the advancements in breeding technologies coupled 
with a better understanding of individual cattle genomics have made it possible 
to breed for disease resistance to specific problematic diseases affecting the 
dairy industry. The causative agent of bovine tuberculosis, Mycobacterium 
bovis a pathogen from the same family as MAP has been shown to have a 
genetic basis to host susceptibility (Allen et al, 2010) with a range of studies 
indicating that heritability for TB disease resistance is possible. Bermingham 
et al (2014) carried out a genome-wide association study (GWAS) on female 
Holstein-Freisian cattle concluding that SNP markers for TB resistance occur 
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and therefore genetic variation to bovine tuberculosis occurs in cattle. The 
potential to select for resistance genes towards TB in cattle breeding 
programmes therefore exists. 
Another disease which has been researched due to its impact on loss of 
productivity is mastitis. Mastitis resistance is considered as a functional trait 
with a combination of somatic score, udder depth, fore udder attachment, 
recorded mastitis and body condition score contributing to positive resistance. 
However, despite several years of investigation the heritability of mastitis 
resistance remains at only 4% (CDN, 2013). 
2.7.2 Potential to breed for Johne’s resistance 
Research studies to determine if genetic markers exist in order to predict 
Johne’s disease susceptibility have been completed. However, genetic 
susceptibility to Johne’s disease is complex. For example, in a recent GWAS 
completed by Minozzi et al (2012) it was found that multiple loci (11 different 
chromosomes) are associated with MAP infections in cattle. This is furthered 
complicated by breed factors with a study completed by Ruiz-Larranaga et al 
(2010) finding that in Braham-Angus crossbred cattle, biomarkers for MAP 
infection were found in the caspase associated recruitment domain 15 
(CARD15). The study revealed however, that the gene is not found in Holstein 
cattle and is therefore unrepresentative of many dairy cattle.  
Specific immunological genes can be targeted, for example the Solute Carrier 
Family 11 Member 1 (SLC11A1) gene has been identified to exhibit 
polymorphisms that are associated with MAP susceptibility in cattle. The 
SLC11A1 gene is an iron transporter protein which is primarily expressed in 
phagosomes (Purdie et al, 2011). An early study completed by Arias et al 
(1997) found that the protein exhibits pleiotropic effects on the early innate 
macrophage in the mouse model, leading to regulation of inducible nitric oxide 
synthase in order to control intracellular bacterial growth.  
As outlined in Section 2.4.5, the MHC is involved in antigen presentation to T-
cells resulting in the secretion of IFN-gamma. IFN-gamma leads to 
macrophage activation as well as NO production. MHC genes are therefore 
key targets for genetic association studies towards MAP. Human studies have 
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identified that susceptibility has been associated with mutations in IFN-gamma 
receptor genes (Vosse, Dissel and Ottenhoff, 2009) in animal studies, 
research has shown that in Merino flocks of sheep, an association of MHC 
polymorphisms to MAP infection susceptibility has also been found (Reddacliff 
et al, 2005). These associations show that there is genetic potential to breed 
for MAP resistance with SNP technology ensuring that specific genes can be 
identified for breeding programmes. The heritability of these traits however, 
have not been investigated.  
2.7.3 Problems with breeding for disease resistance  
Despite there being an opportunity to breed for specific disease resistance, 
there are problems associated with breeding for specific traits. In addition to 
low heritability, breeding for single traits can have negative effects on other 
desirable traits. For example, milk production traits which, in the past have 
commonly been selected by breeders have shown to have negative 
consequences for mastitis incidence in dairy cattle. An unfavourable genetic 
correlation between milk yield and mastitis resistance, as well as mastitis 
resistance being of low heritability has meant that a reduction of mastitis 
through traditional breeding has been unsuccessful (Kadri et al, 2015).  
Another problem in breeding for disease resistance is that AMIR and CMIR 
have a negative genetic correlation11 (Thompson-Crispi, Miglior and Mallard, 
2013). This means that in breeding for a reduction of one specific disease such 
as mastitis, which is predominantly met by AMIR the breeding could 
inadvertently be breeding out a CMIR response which defends against 
intracellular pathogens such as Mycobacterium therefore reducing the 
animal’s ability to defend against a broad range of infectious organisms 




                                                          
11 In the diseases studied: mastitis, retained placenta and ketosis 
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2.8 High Immune Response Technology 
The literature has demonstrated that disease prevalence in dairy systems can 
be problematic. It poses a risk to farm economics, risks the welfare of cattle 
and in diseases such as Johne’s disease there is also the potential for zoonotic 
threats (Botsaris et al, 2016). In addition, it has been discussed how disease 
resistance is increasingly being bred for through the development of breeding 
technologies which can mark genes in order to encourage certain health traits. 
However, despite the advancements in technology, breeding for disease 
resistance is often based on a specific disease such as mastitis and at present 
does not cover a multitude of diseases in the UK. This has been shown in 
practice recently with the ‘TB Advantage’ index being published by the Dairy 
division of the Agriculture and Horticulture Development Board on the 19th 
January 2016. This index is designed to help farmers breed for enhanced 
resistance to bovine tuberculosis in the UK, however, with a heritability of 9% 
and a focus on a single trait it does not cover a range of diseases although 
bulls in the index do rank as high health performers (AHDB, 2016c). 
According to Thompson-Crispi, Miglior and Mallard (2013): ‘A robust and 
balanced immune system of the dairy cow is vital for the protection against 
economically important diseases’. This is the basis of an immune technology 
in disease prevention, patented as the High Immune Response (HIR) 
technology. This technology was developed through an investigation of the 
negative correlation between AMIR and CMIR and uses a test system in order 
to identify cattle which have high and balanced AMIR and CMIR and in turn 
has been proven to reduce disease such as mastitis, metritis, retained 
placenta, displaced abomasum (Mallard et al, 2011) and pneumonia (Semex, 
2015) as well as increasing farm profits, improving milk quality and assuring 
animal welfare is at a high standard (Mallard et al, 2011). As well as promoting 
a good adaptive immune response through a balanced and high AMIR CMIR 
ratio, the HIR technology also increases the efficiency of the animal’s innate 
immune response (Mallard et al, 2014).  
The benefits that the HIR technology provides include: 
 Lower disease occurrence and severity 
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 Reduced veterinary intervention and cost 
 Better vaccination response 
 Colostrum quality improvement 
 Testing can be from 2 months old 
 Lifelong test 
 Cost analysis= significant savings in HIR identification (Thompson-
Crispi and Mallard, 2011) 
2.8.1 Genetics and HIR  
Research carried out by Mallard et al (2011), has found that selective breeding 
for high (HIR), average (AIR) and low responders (LIR) to disease is possible 
in rodents, poultry, pigs and cattle. In addition to the evidence supporting the 
breeding of genetic resistance to disease into these livestock species, 
research has also shown that the heritability of HIR is sufficient enough to allow 
genetic improvements within the herd, especially when combined with in vitro 
fertilisation and embryo transfer methods. According to Semex (2015), the 
heritability of immune response (IR) in cattle is 30% which shows a significant 
genetic component in IR traits and is at a similar rate of production traits at 25-
35% such as milk yield which is commonly bred for in the dairy industry. This 
compares to other traits which are routinely bred for such as fertility which 
exists at a 4-7% heritability rate, longevity 8-10% and calving ease 6-7%. As 
previously outlined in the literature, heritability for resistance to specific 
diseases are even lower than these commonly used breeding traits and are 
generally lower than 10% (as referred to previously with the ‘TB Advantage’). 
Daughters of HIR sires have been shown to have 44% less mastitis and 25% 
less calf pneumonia (Mallard et al, 2014). The potential to breed HIR genetics 
in to dairy herds therefore has promising outcomes (Thompson-Crispi and 
Mallard, 2010). 
2.8.2 HIR test system 
The HIR test system allows dairy managers to identify cattle as low, average 
or high responders with results enabling a selection of cattle to breed from in 
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order to gain the genetic merit of immune response as well as identifying cattle 
with low immune response either for culling out or applying tailored 
management such as enhanced vaccination programs or through nutrition 
techniques to ensure good welfare standards are met. 
The HIR test is carried out over 15 days with 3 farm visits (see Figure 5). Firstly 
cows are immunized with the patent test antigen system in order to measure 
their ability to mount an immune response towards a challenge. Blood and or 
milk samples are then collected in order to measure the animals AMIR. CMIR 
is measured through a skin fold test and the two results correlated. It is critical 
that for HIR both tests provide a sufficient balanced immune response. 
Figure 5: HIR Test procedure 
Finally, cattle are ranked according to their ability to pass on the genetic 
immune response based on EBVs (Thompson-Crispi and Mallard, 2010).  
2.8.3 Application 
As discussed previously in the literature genomics have enabled breeding 
practices to revolutionise, especially through the use of SNP chip technology. 
Genetic gain can now be achieved at a rapid rate through a reduction of the 
genetic interval and accuracy of selection. The HIR technology combined with 
genomics can therefore increase immune response objectives in breeding 
programs and accelerate the time in which it takes to gain a herd with HIR 
status. In addition, the HIR technology does not require genetic manipulation 
and can therefore be bred for naturally, thus avoiding the controversies 
surrounding genetically modified organisms (GMO’s) (Mallard et al, 2014).  
Some materials have been removed due to 3rd party copyright. The 




Through research in Canada it has been found that around 200 SNP markers 
are associated with HIR (Thomson-Crispi and Mallard, 2010) although this is 
expected to have increased over time with further research in the field. 
In practice, the patent of the HIR technology is owned by Semex who have 
launched a line of Immunity+ sires (Semex, 2015). These sires are currently 
being used in dairy breeding and are therefore passing on the heritability of 
immune response to their daughters. Previous research found that high AMIR 
is correlated with lower milk yields which initially makes the test system and 
use of HIR in breeding practices unfavourable, however it has been found that 
high CMIR is correlated with high milk yield and therefore when both traits are 
selected for, ultimately there are no adverse effects on milk yield (Watger et 
al, 2003). A strong response has been found towards the technology in the US 
and Canada (Mallard et al, 2011) however the technology is not widely 
recognised in the UK and therefore research into how HIR could aid disease 
control of Johne’s disease has had little acknowledgement.  
2.8.4 Potential for HIR in the UK  
The literature has outlined the implications that Johne’s disease has for the 
welfare of cattle (Gov.UK, 2012) as well as the economic losses experienced 
by farmers with Johne’s disease infected herds (Guitian, 2015). Potential 
exists in breeding programmes with the identification of gene markers which 
contribute to disease resistance (Minozzi et al, 2012) (Purdie et al, 2011), 
however these genes are heritable at low rates as well as posing a risk to other 
desirable traits (Hinger, Brandt and Erhardt, 2008) (Kadri et al, 2015). It is 
therefore believed that the HIR technology, which focuses on equipping cattle 
with broad based disease resistance (Thompson-Crispi, Miglior and Mallard, 
2013) and has shown in preliminary studies that HIR cattle are less likely to 
test positive for Johne’s disease (Semex, 2015), is a breeding tool which can 






2.9 Hypothesis Formation 
The literature has indicated that breeding for health is not only viable but also 
recognised by the industry as a key performance trait. Through an analysis of 
the literature it is hypothesised that cattle with high immune response traits will 
be better equipped immunologically to defend against pathogens such as MAP 
due to having a better innate response as well as high CMIR which defends 
against intracellular pathogens. Preliminary studies also indicate that cattle 
with HIR EBVs are less likely to be test positive for Johne’s disease.  
The researcher investigated macrophage response towards whole cell 
deactivated MAP and two proteins from MAP, from cattle with the following 
EBVs: H (AMIR) H (CMIR), L (AMIR) L (CMIR), H (AMIR) L (CMIR) and L 
(AMIR) H (CMIR). In order to measure the immune response, Nitric Oxide (NO) 
and pH of the phagosome was measured.  
The researcher has made the following alternate hypotheses (H1): 
 HH macrophages will have higher production of NO  
 HH macrophages will have a lower drop in pH 
 LL macrophages pH will not drop as significantly- NO will also be 
produced at lower rates 
 LH macrophages will produce slightly more NO and drop pH to a lower 
level than HL macrophages, as they have a higher CMIR. However, as 
this research will be recording an innate response it is likely that there 
won’t be a significant difference between the two  
The null hypothesis (H0) is that macrophages from each cow, regardless of 





3.1 Aims and objectives of the research  
The aim of this research project was to complete an in-vitro investigation in 
order to determine if macrophages from cattle with high immune response 
traits were more capable of mounting a successful immune response towards 
MAP pathogens (deactivated) and recombinant proteins from MAP12 than 
cattle with a low immune response. In order to measure immune response the 
researcher recorded NO release as well as the pH of the phagosome, both 
indicators of immune response as defined in the literature review.  
The key research objectives behind this methodology are: 
 To investigate if HH macrophages produce higher NO than LL 
macrophages, and if HH drop pH lower than LL 
 To establish if there are any differences between HL and LH 
macrophage types in terms of immune response 
 To establish whether HH EBV cattle be used to breed for increased 
resistance to Johne’s disease 
 To investigate if the UK dairy industry could benefit from adopting the 
HIR test system at a commercial scale 
3.2 In-vitro Experiment 
In total 16 Holstein cows (mid-lactation with no clinical sign of disease and 
negative for Johne’s disease) were sampled from the University of Guelph’s 
cattle research station in Elora, Ontario. Although 16 samples were run, two 
samples were lost due to macrophage infection in-vitro. The researcher 
therefore only used three cow samples per cohort (12 cows, in total). The cattle 
had been tested for immune response previously with the following HIR EBVs: 
 
 
                                                          




Table 1: HIR EBV’s of cattle selected for research study  
Cow Number AMIR CMIR EBV 
4221 1.13 -1.41 HL 
4322 1.21 -1.47 HL 
4200 0.91 -1.00 HL 
4215 0.94 -1.58 HL 
4095 -1.79 1.13 LH 
4314 -1.04 1.19 LH 
4323 -2.16 1.11 LH 
4349 -2.14 1.95 LH 
4209 1.83 1.13 HH 
4345 1.33 1.84 HH 
4056 0.98 2.06 HH 
4238 0.88 1.49 HH 
4192 -1.29 -1.89 LL 
4212 -1.40 -1.46 LL 
4233 -1.14 -1.41 LL 
4294 -1.75 -1.25 LL 
 
The cattle were then further split into four cohorts: 
 Low AMIR, Low CMIR (LL) 
 High AMIR, High CMIR (HH) 
 Low AMIR, High CMIR (LH) 
 High AMIR, Low CMIR (HL) 
 
Table 2: EBV cohorts  
 
LL HH 
4214, 4192, 4294, 4233 4056, 4345, 4209, 4238 
LH HL 
4349, 4095, 4314, 4323 4221, 4322, 4200, 4215 
43 
 
In order to minimise bias the researcher ran a LL sample at the same time as 
an HH sample and a LH sample at the same time as an HL sample. It was 
decided that only 2 samples could be run per day due to the complexity and 
time consumption of the procedure, this ensured that blood was not standing 
for pro-longed periods of time which was found to have a negative effect on 
macrophage viability and yield. The preliminary research phase also 
highlighted that macrophage yield was highly dependent on the blood 
collection method and that the inversion of EDTA vacutainer tubes was 
essential in the ultimate viability of the macrophages. 
The procedure followed was derived from Okudolo and Cash (2015) and 
optimised by Emam (2015). The procedure is outlined below: 
Day 0: Culturing Blood Mononuclear Cells 
1. Collect 10 EDTA coated vacutainer tubes of blood from each research 
cow (tube to be inverted several times following collection) 
2. Prepare cell culture hood using 70% ethanol  
3. Centrifuge for 20 minutes at 1200g at room temperature (brake on) 
4. Remove the buffy coat layer from all tubes from one animal with a 
transfer pipette and put into a 50ml conical tube, dilute up to 15ml with 
DPBS 
5. Add 15ml of histopaque into a SepMate-50 tube through the central hole  
6.  Keeping the SepMate-50 tube vertical, add the diluted sample of buffy 
coat by pipetting down the side of the tube, slowly.  
7. Centrifuge for 12 minutes at 1200g at room temperature (brake off) 
8. Pour off the top layer (which contains mononuclear cells) into a 50ml 
tube. Do not hold the SepMate-50 tube in the inverted position for longer 
than 2 seconds. Mix with a transfer pipette and top up to 45ml with 
DPBS 
9. Centrifuge for 10 minutes at 100g at room temperature (brake on) 
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10. Remove the supernatant using a 25ml pipette. Use a transfer pipette to 
take the last 2ml of supernatant very slowly (pellet will be loose) 
11. Add 45ml DPBS and re-suspend the pellet using a transfer pipette. 
12. Centrifuge for 5 minutes at 400g (brake on) 
13. Pour off the supernatant into the waste bucket (invert tube slowly and 
only once) 
14. Add ~1ml of autoclaved distilled water to the tube with the pellet to lyse 
and red blood cells left in the pellet. Re-suspend by pipetting up and 
down with a transfer pipette. IMMEDIATELY add DPBS to 50ml (this 
should be done in less than 5 seconds) 
15. Centrifuge for 5 minutes at 400g at room temperature (brake on) 
16. Pour off supernatant being sure not to dislodge the pellet and add 10ml 
of DPBS to re-suspend 
17. Add 50µl of cell suspension into a 0.6 micro-centrifuge tube and then 
add 450µl of DPBS (1:20 dilution). Pipette up and down to mix. 
18. Use a Moxi-Z cell counter13 (S type cassette) to determine the cell 
concentration which should be ~10e6 with a moxi population index 
(MPI) of greater than 0.90 (Multiply the cell count by the dilution factor 
10 to get actual cell concentration of the sample) 
19. Calculate the amount of cell media to be transferred to a 75ml culture 
flask by dividing cell concentration by 7.5e7 (see Figure 6) 
                                                          
13 A Moxi Z Cell Counter performs cell count and size measurements for particle sizes of 3 – 20 
microns (Type S cassette). It also provides an assessment of mammalian culture viability using a 





Figure 6: Calculation example for 75ml flask 
 
20. Transfer calculated amount of cell media to the culture flask along with 
15ml of room temperate monocyte attachment media14 
21. Incubate for 2 hours at 37ºC at 5%CO² 
22. Remove the flask from the incubator and wash twice using room 
temperature DPBS to remove all non-adherent cells 
23. Add 20ml of room temperature AIM-V media and return to the incubator 
(37ºC at 5%CO²) 
Day 2: Change Media 
24. Add 50% of the total volume of fresh AIM-V media (10ml) 
25. Return flask to incubator (37ºC at 5%CO²) 
Day 5: Replace Media 
26. Take out 50% of the media (15ml) and replace with 15ml of fresh AIM-
V 
27. Return flask to incubator (37ºC at 5%CO²) 
 
 
                                                          
14 Monocyte Attachment Medium allows efficient adherence selection of Monocytes from freshly 
isolated Mononuclear Cells. It also maintains optimal cell health. Large numbers of 80-90% pure 
monocytes can be obtained through the use of monocyte attachment medium (PromoCell, 2013) 
Sample: 4314 (LH) 
 
Dilution factor 1:10 
MPI- 1.00 
1.01e6 cells/ml = 1,010,000 
1,010,000 x 10 = 10,100,000 
75,000,000 ÷ 10,100,000 = 7.42 ml of cell media to transfer 
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Day 7: Harvest Macrophages 
28. Take flask out of the incubator and wash twice using room temperature 
DPBS 
29. Add 10ml of ice cold DPBS containing 5mM EDTA 
30. Place the flask on ice for 15 minutes, move the flask over the ice for 30 
seconds and tap the flask on the edge of a bench every 5 minutes, when 
the flask is returned to the ice keep it moving for the initial 30 seconds 
31. Transfer the detached cells into a 50ml conical tube 
32. Add 10ml of pre-warmed 1X TrypLE® to the flask and incubate for 15 
minutes (37ºC at 5%CO²) 
33. Take the flask out of the incubator and into the hood, load the media 
into the pipette and flush over the surface of the flask several times  
34. Return the flask to the incubator (37ºC at 5%CO²) for 5 minutes 
35. Repeat step 33 and then transfer the cell solution into the conical tube 
from step 31 
36. Centrifuge the concial tube containing the cell solution for 10 minutes at 
600g (brake on, room temperature) 
37. Discard the supernatant and re-suspend the pellet in 2ml of room 
temperature AIM-V  
38. Make a 1:10 dilution of cell suspension in DPBS by diluting 10µl of cell 
suspension with 90µl of AIM-V 
39. Use the Moxi cell counter (M type cassette) to count the cells and then 
multiply the cell count by the dilution factor to get the actual cell count 
40. Cells to be added to a 90 well flat bottomed plate and to a phago-assay 
clear bottomed plate at 50k cells/well, in order to determine the amount 
of cell media to add to each well follow the C1 x V1 = C2 x V2 formula, 
see Figure 7: 
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Figure 7: Calculation example for plating  
 
41. Return the plated cells to the incubator for 24 hours (37ºC at 5%CO²) 
Day 8: Macrophage Challenge  
The macrophages from each sample were challenged on day 8 with 
recombinant proteins from MAP, Protein 1 (P1) and Protein 2 (P2) as well as 
whole cell heat deactivated MAP. In order to optimise the experiment 4 cattle 
samples were run by the researcher prior to the 16 cow sample so that the 
most effective challenge dose could be determined. It was found that the most 
effective challenges were protein 1 at a dose of 0.1 µg/ ml (C1) and protein 2 
at a dose of 1 µg/ml (C2). The most effective for the whole cell deactivated 
MAP was found to be at a ratio of 10:1 (MAP: MØ) 
Tables 3 and 4 show the plate layout and pathogen challenge used for all 16 
samples, in order to measure pH as well as nitric oxide separate plates were 
used. Replicates ensure standardisation and reduce error. 
 
Sample: 4314 (LH) 
 
Dilution factor 1:10 
9e4 cells/ ml = 90,000 x 10 (dilution factor) = 900,000 cells/ ml 
                            C1                        x                       V1 
                    900,000 (cells/ml)                  2.1ml (amount of cell stock) 
 
                            C2                        x                       V2 
       500,000 (cells to be added/well)                         ? 
 
C1 x V1 = 1,890,000 ÷ C2 500,000 = 3.78ml 




before phago assay e-coli solution being added to each well at 100µl/ well. The 
plate was then returned to the incubator for a further 3 hours. This method was 
used as a suitable pH indicator had not been conjugated to MAP or MAP 
recombinant proteins, as the protein challenges had been introduced 24 hours 
previously the macrophages would have begun to phagocytose the pathogen 
and therefore using the conjugated e-coli served as a method of reading the 
internal pH of the phagosome without interfering with the results of the MAP 
recombinant proteins significantly.  
Following 3 hours of incubation the plate was removed from the incubator, the 
contents from each well were removed and each well was washed with 150µl 
of DPBS. The plate was then read using a pH reader in the laboratory and 
results recorded.  
Day 10: Nitric Oxide (NO) Concentration Experiment  
The NO experiment was carried out following 48 hours of macrophage and 
pathogen challenge co-culture. The experiment followed the Greiss Reagent 
System, a protocol from Promega and is outlined below: 
1. Make a 1:10 dilution of nitrate solution with AIM-V, vortex well to mix 
2. Use a new 96-well flat-bottom enzymatic assay plate. Add 50µl of AIM-
V to first two columns starting at B1 and B2 (leave A1 and A2 empty) 
3. Add 100µl of the nitrate solution to the top two wells (A1 and A2) 
4. Take 50µl from the top two wells to the second two wells (B1 and B2) 
and mix 10 times with a pipette 
5. Repeat process until the two wells before the final two wells are 
reached- take 50µl out and dispense (the final 2 wells will remain as 
AIM-V only and act as the control) this will create the nitrate standard 
reference curve (see Figure 8 for visual description) 
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6. Add 50µl of the supernatant from each well from the co-cultured 
macrophage and challenge plate to each well in the enzymatic assay 
plate 
7. Add 50µl of sulfanilamide solution to each well, cover and leave for 10 
minutes in the dark 
8. Add 50µl of N-1-napthylethylenediamine dihydrochloride (NED) solution 
to each well, return to the dark for a further 10 minutes 
9. Read the plate using a reader with a 520–550nm filter  
(Promega, 2009) 
3.3 Data Collection and Statistical Analysis 
All data that was collected through the experiment (NO release, pH read out) 
was entered into Excel spreadsheets. The data was then analysed through 
GenStat fifteenth edition, using an analysis of variance (ANOVA) test. 
Histograms were also produced in order to visually explore the data. 
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This form of research is quantitative in nature as it based on numerical 
elements using figures, numbers and mathematical equations to help analyse 
data (Dransfield et al 2004:621). This will enable the researcher to produce 








Experimental data can be found in Appendix B. A full GenStat report can be 
found in Appendix C.  
3.1 Nitric Oxide Release Experiments 
An analysis of the data through GenStat using the two-way analysis of variance 
(ANOVA) method showed that there were no statistically significant differences 
between the EBV groups for NO release (probability score of <0.05 required 
to show statistical significance). 
Please note, the control for each experiment was 0, the control was not used 
within the statistical analysis in order to ensure the results weren’t skewed. 
This applies to figures 9, 10, 13 and 14. 
Figure 9: Genstat two-way ANOVA results for NO release 
 
Source of variation explained in footnote15 
The researcher also ran contrast testing to measure HH against LL and HL 
against LH to determine statistical difference. Although the HH EBV produced 
a higher concentration of NO throughout the experiments, the difference 
between the two cohorts was not statistically significant.  
                                                          
15   
d.f degrees of freedom in the source 
s.s the sum of squares due to the source 
m.s the mean sum of squares due to the source 
v.r variance ratio 
F-Pr the P-value- Probability  
 
 
Source of variation     d.f.       s.s.       m.s.    v.r.  F pr. 
 
EBV                        3     247.83      82.61    7.35  0.001 
Treatment                  2      70.36      35.18    3.13  0.062 
EBV.Treatment              6      31.07       5.18    0.46  0.830 
Residual                  24     269.80      11.24 







hypothesis that the HH cohort would produce drop the pH to a lower level than 













This research study has investigated the immune response of cattle towards 
MAP pathogens, in vitro. Previous research studies have found that once MAP 
pathogens enter the host they are primarily met by macrophage cells as part 
of the innate immune response (Rue-Albrecht et al, 2014). The production of 
nitric oxide and an internal drop in the pH of the macrophage, are both 
mechanisms of immune response (Janeway et al, 2005) and work to eliminate 
invading pathogens.  
The HIR technology has been shown to reduce a range of diseases including 
mastitis, metritis and displaced abomasum as well as preliminary research 
showing that cattle are less likely to test positive for Johne’s disease. HIR cattle 
have been shown to have a stronger innate immune response than LIR cattle 
(Mallard et al, 2014). The HIR technology works by measuring the two 
components of the adaptive immune response, AMIR and CMIR. If both AMIR 
and CMIR are high, cattle have a good broad based immune response and 
can tackle a range of intracellular and extracellular pathogens. As MAP is an 
intracellular pathogen it is important that CMIR is high, but as identified in the 
literature review, AMIR and CMIR can be negatively genetically correlated 
(Thompson-Crispi, Miglior and Mallard, 2010) and therefore by breeding for 
resistance to one specific disease such as with TB breeding strategies, it can 
have implications for broad based disease resistance.  
The researcher measured NO production and pH drop of four immune 
response EBV’s, HH, LL, HL and LH. The null hypothesis was that all cohorts 
would produce approximately the same amount of NO as well as pH being 
equal across the EBV groups. The alternative hypothesis however, stated that 
HH macrophages would have higher NO production than LL macrophages as 
well as dropping pH to a lower level. It was also hypothesised that LH 






4.1 Nitric Oxide Production 
As outlined in the results section, NO release from HH macrophages was 
higher than LL macrophages. However, the data collected in this research 
study did not show any statistically significant differences. A two-way analysis 
of variance (ANOVA) test examines the influence of two independent variables 
on one continuous dependable variable (VSNi, 2016). In this research study, 
the two independent variables were treatment (whole cell deactivated MAP, 
recombinant protein 1 and recombinant protein 2) and EBV (HH, LL, HL, LH) 
the continuous dependable variable was NO release. 
The alternate hypothesis stated that cattle with a HH EBV, would produce a 
higher concentration of NO than cattle with a LL EBV, based on HH cattle 
having a better innate and adaptive immune response (Mallard et al, 2014). 
Whilst the alternate hypothesis was proved correct with HH EBV cattle having 
a mean production of 10.28 compared with LL EBV cattle which produced a 
mean of 8.25, in terms of statistics no significance was found, even when 
ANOVA contrast testing between the two EBVs was employed. This means 
that the alternate hypothesis should be rejected statistically. Despite the 
alternate hypothesis being rejected in this study, it should be noted that the 
sample size was small and therefore a larger group of animals should be tested 
before the alternate hypothesis is fully rejected.  
The HL and LH EBV cattle exhibited very little difference in terms of NO 
production with HL and LH cattle producing means of 4.13 and 4.32 
retrospectively. The alternate hypothesis stated that LH macrophages would 
produce a slightly higher concentration of NO, and although marginally higher 
the alternate hypothesis is rejected due to there being no statistical 
significance.   
The researcher expected that cattle with LH EBVs would produce a higher 
concentration of NO than those with HL EBVs due to MAP being an 
intracellular pathogen and therefore requiring a strong CMIR to eliminate it. 
The macrophages were challenged on day 8 of the experiment with pH being 
recorded on day 8 and NO being recorded on day 10. In a live host, this stage 
of infection would be met by an innate response which is non-specific and 
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therefore does not confer adaptive AMIR and CMIR responses. It is therefore 
assumed that this is why HL and LH EBV cattle didn’t produce significantly 
different immune responses at this stage within an in vitro experiment. The 
nature of the experiment being in vitro also limits the complex reactions 
between the immune response cells such as cytokine release and the 
complement system which would occur in an in vivo experiment.  
ANOVA testing also enabled the researcher to compare treatments. It was 
found that the recombinant protein 2 produced the highest NO mean at 8.26 
across all EBVs (MAP whole cell, 7.09 and recombinant protein 1, 4.89). The 
researcher expected the proteins to produce a higher reaction than the MAP 
whole cell as they would bind directly to the macrophage cell surface. Whole 
cell pathogens on the other hand were predicted to cause less of a reaction 
due to cell surface reactors having to pass over each other before the 
macrophage recognised the MAP pathogen as a foreign body. It should be 
noted that the MAP pathogen was deactivated and therefore if live MAP 
pathogens were used a stronger reaction may have been observed.  
4.2 pH drop 
The pH experiment enabled the researcher to determine if macrophages had 
the ability to drop the intracellular compartment to an acidity capable of 
promoting phagolysosomal fusion and therefore eliminating the pathogen. As 
stated in the literature, MAP pathogens have the ability to evade the host 
immune system by blocking phagolysosomal fusion and therefore have the 
ability to reside in host macrophages (Arsenault et al, 2014). The researcher 
was therefore interested to investigate if HH macrophages were better 
equipped to create an acidic pH than LL macrophages. The researcher 
hypothesised that the HH EBV macrophages would drop pH to a lower level 
than LL macrophages and the LH macrophages would drop pH to a lower level 
than HL macrophages. The null hypothesis was that no significant difference 
would be found between groups.  
Genstat analysis, using a two-way ANOVA found that there were no 
statistically significant differences between EBV groups. Contrast testing found 
that although not statistically significant a probability score of 0.061 existed 
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between HH and LL macrophages, indicating that difference did occur and that 
further investigation with a larger cohort of subjects should be undertaken. The 
researcher also measured the difference between the LL and LH EBV groups 
which had a probability of 0.012 making it a statistically significant result.  
The researcher notes that the EBV group with the largest pH drop was the LH 
group. Whilst this indicates that this EBV had the most successful immune 
response towards the MAP challenge in vitro and could therefore work 
successfully to promote Johne’s disease resistance, breeding for CMIR 
specifically has the potential to inadvertently breed out AMIR due to the 
negative genetic correlation between the two types of adaptive immunity, 
leaving the host more susceptible to extracellular diseases such as mastitis 
(Thompson-Crispi, Miglior and Mallard, 2013). In addition, this experiment 
predominantly measured the innate response and therefore the adaptive 
immune response which would be activated several days after the challenge 
may have produced an even stronger CMIR response making the LH EBV a 
desirable cohort for breeding specific resistance to Johne’s disease, however 
as previously mentioned it is recommended that broad based disease 
resistance is bred for and not single traits such as CMIR specifically 
(Thompson-Crispi, Miglior and Mallard, 2013).  
The researcher used the two recombinant proteins to measure pH due to the 
complexity of conjugating whole MAP to the florescent dye used to measure 
pH. The ANOVA test showed that recombinant protein 2 promoted a stronger 
reaction than protein 1. Reports in the literature investigated the use of 
vaccination as a method to reduce Johne’s disease susceptibility and 
prevalence within herds (NADIS, 2016). It is suggested that recombinant 
protein 2 could be trialled as a vaccination component as it would not result in 
infection but successfully enable the host to identify the pathogen and 
therefore result in protective immunity based on an initial innate, followed by a 
CMIR response.  
This research was completed using recombinant proteins from MAP, as 
opposed to the live whole cell. It is known that mycobacteria species use a 
range of mechanisms in order to evade the host immune response (Arsenault 
61 
 
et al, 2014) including phagolysosomal blocking with sulphide reactions and the 
secretion of liquid phosphate (SapM). Brumell and Scidmore (2007) found that 
deactivated MAP did not produce SapM which effectively prevents 
phagolysosomal fusion, whereas whole cell active MAP did. It should therefore 
be noted that if the researcher were to have used whole cell live MAP, the 
macrophages may not have been as successful in blocking the reaction. On 
the other hand, a greater variation could have been seen between the genetic 
cohorts as shown in research by Pais and Appelberg (2000) which found that 
only 10-15% of cattle exposed to MAP became infected which was influenced 
by family and genetics.  
 
4.3 Application of HIR in the UK  
This research has shown that there is potential to use the HIR technology to 
reduce diseases such as Johne’s disease. The literature review has indicated 
that preliminary research has shown that the HIR technology can reduce 
susceptibility to Johne’s disease (Mallard et al, 2014). The research carried 
out as part of this study supports this assumption, although a considerable 
amount of further laboratory research as well as in vivo experimentation is 
required to fully understand the interactions at a higher level. The researcher 
also acknowledges that this research study measured immune response at an 
innate stage and therefore the adaptive response was not be measured.  
4.4.1 Breeding  
As described in the literature, HIR traits are heritable at 30% (Semex, 2015). 
Heritability of immune response could therefore be achieved over a relatively 
short period of time in UK dairy herds, especially if breeding technologies such 
as in vitro fertilisation and embryo transfer are employed (ABRI, 2016). 
Additionally, the heritability of single traits are generally lower than HIR. For 
example, TB resistance is heritable at 9% (AHDB, 2016 c) it can be argued 
that the causative agent of TB is closely related to that of Johne’s disease, a 
similar heritability rate could be found although as described in the literature 
due to the multiple loci associated with Johne’s resistance disease, heritability 
is difficult to predict.  
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It is argued that breeding for HIR is beneficial in terms of promoting broad 
based disease resistance and as stated throughout this research study is 
recommended in order to defend against a range of intracellular and 
extracellular pathogens (Thompson-Crispi, Miglior and Mallard, 2013) (Mallard 
et al, 2014). 
4.4.2 Potential problems 
The researcher has identified that potential problems exist in breeding for 
resistance to specific diseases due to the negative correlation between AMIR 
and CMIR. In addition, the problems associated with breeding cattle with a LH 
EBV have also been discussed (Section 4.3). 
This research study investigated the difference between immune response 
EBVs at an innate level, based on the evidence that HIR cattle have a stronger 
innate response that LIR cattle (Mallard et al, 2014). HIR cattle also promote 
a better adaptive immune response which is key to management of MAP within 
the host. As identified in the literature, MAP is predominantly met by CMIR 
(characterised by the production of IFN-gamma) which activates macrophages 
to kill the bacteria, due to its intracellular nature. A successful CMIR response 
will result in elimination of the pathogen however, if the pathogen is able to 
evade the host’s immune response and reside within macrophages the 
immune response will shift to one that is mediated by AMIR (Arsenault et al, 
2014). It is at this stage in live animals that the Johne’s disease test will identify 
infected animals.  
AMIR is activated once production of IFN-gamma is reduced and is 
characterised by the production of antibody. Whilst it is known that a HH EBV 
will promote broad based disease resistance, the researcher acknowledges 
that further research needs to be completed in order to determine whether a 
strong AMIR could lead to the response switching from a protective CMIR to 
an AMIR at an earlier stage. Research studies have so far not been able to 
define whether MAP specific antibodies play a significant role in controlling the 
rate of bacterial shedding or conversely increase the rate of uptake of bacteria 
by macrophages (Mundo et al, 2008). According to De Silva et al (2013), a 
strong CMIR resulted in delayed shedding in a sheep model, whereas Koets 
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et al (2002), found that both CMIR and AMIR were equally impaired during the 
later infection stages of Johne’s disease. Magombedze, Eda and Ganusov 
(2014) suggested that one factor that influenced the switch between a CMIR 
and AMIR was the degree of competition between the two arms of response. 
This fits with the assumption made by the researcher above and is in relation 
to the principles of the HIR technology. With this assumption in mind, HL cattle 
could be less resistant to MAP than LH cattle, this was also represented in the 
data analysis. As previously mentioned however, breeding specifically for LH 
cattle would result in the host being more susceptible to intracellular infections 
as well as the AMIR response in Johne’s disease potentially helping to 




This research project has shown that statistically significant differences did not 
exist between the four EBV groups of cattle (HH, LL, HL, LH) when 
macrophages were challenged in vitro with whole cell deactivated MAP and 2 
recombinant MAP proteins for NO release, however there was a statistically 
significant result between the HL and LH groups for pH. The researcher 
measured two immune responses which indicate susceptibility/ resistance. 
Although the data analysis did not provide a statistical difference, it was 
observed that HH macrophages produced more NO and dropped pH to a lower 
level than LL macrophages, as predicted in the alternate hypothesis.  
In addition, it was found that LH macrophages produced slightly more NO than 
HL and LL macrophages as well as dropping pH considerably lower than HL 
macrophages and statistically significantly lower than LH macrophages for pH. 
The literature indicates that MAP infection is primarily met by an innate immune 
response, this is followed by an adaptive immune response which is 
predominantly cell mediated (Arsenault et al, 2014). If the CMIR is unable to 
clear the pathogen, AMIR takes over and is argued to contribute to pathogen 
dissemination (Mundo et al, 2008) (Magombedze, Eda and Ganusov, 2014). 
Although the reason for the switch between CMIR and AMIR is poorly 
understood it is suggested that it could be due to competition between the two 
arms of response (Magombedze, Eda and Ganusov, 2014). Based on this 
assumption and the results of this research study suggest that the ideal EBV 
for breeding resistance to Johne’s disease is the LH EBV. However, breeding 
for specific disease resistance has a number of problems due to the negative 
correlation between the two arms of immune response (Thomson-Crispi, 
Miglior and Mallard, 2013) which in the case of LH cattle, could lead to the 
animal being more susceptible to extracellular pathogens.  
The aim of this study was to investigate whether differences in immune 
response towards MAP existed between cattle EBV groups. Although no 
statistical significance was identified, clear differences were observed between 
groups and therefore it is advised that further in depth study is undertaken in 
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vitro in order to determine if HIR cattle are more successful at promoting an 
immune response toward MAP.  
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6 Limitations and Recommendations  
This study has been limited in a number of ways. The key limitation was 
researcher experience with cell culture and macrophage isolation. The process 
of macrophage isolation from blood is complex and therefore the researcher 
needed to become confident in the research procedure before running actual 
samples which reduced the available time for data collection. In addition to 
researcher experience, the methodology also needed to be optimised which 
also reduced the available time to collect data and therefore reduced the 
number of animals in the experiments. 
The research phase was carried out over a period of three months with each 
experiment being run over two weeks. Although the process of macrophage 
isolation had already been optimized by Emam (2015), a number of issues 
arose during further optimization and experimentation which need to be taken 
into account when analysing the results. One of the key issues observed was 
the method of blood collection. For each animal, EDTA vacutainer tubes of 
blood were taken, EDTA tubes help to prevent clotting, however in order to 
ensure this, it is important that the tube is inverted during and after blood 
collection in order to mix the anticoagulant. It was identified that due to the time 
constraints of the research facility, the tubes were not being inverted fully and 
therefore the viability of the macrophages were implicated due to clotting. The 
researcher observed that within a cohort of four cows (HH, LL, HL and LH) the 
blood collection process had an effect on how viable the macrophages were. 
For example, on the 12th October 2015 a HH and a LL cow were identified for 
experimentation. The first cow to have blood taken was the LL cow, the subject 
was calm, remained lying down and inversion of the tube was carried out 
throughout the process of drawing blood. The HH cow however became 
restless after the first tube of blood was drawn and began to move away from 
the researcher, due to this the researcher found it hard to invert the tube 
correctly. It was identified in the laboratory when observing the blood that the 
HH blood was clotted and when centrifuged a very poor buffy coat layer was 
formed. The researcher continued the experiment and measured macrophage 
67 
 
health on day 8. As expected the LL macrophages were healthy, whereas the 
HH macrophages had very poor viability.  
 
Figure 16: Example of poor EDTA blood tube collection and subsequent effect on 
experimental results. NO measurements in µmol mg. 
 
Figure 16 shows the LL and HH experiment results, the LL macrophages 
produced a significantly higher concentration of NO than the HH macrophages. 
This experiment was therefore removed from the analysis due to an error in 
blood collection. This example indicates that caution should be exercised when 
analysing the results as the health of the macrophage is likely to impact 
immune response measurements (NO, pH). It should therefore be noted that 
all macrophages should be tested to ensure that they have equal viability so 
that the reaction is based on EBV. Due to issues with blood collection the 
number of cattle in each cohort was reduced, this meant that whilst statistical 
analysis was possible the results were not as reliable as if a larger cohort of 
cattle were researched.  
In addition to blood collection issues, it is possible that an infection could have 
arisen within the cell culture. In order to ensure that the EBVs can be measured 
equally, it is recommended that this experiment is run again by a researcher 
who has trained in cell culture and macrophage isolation for six months or 
more. This will help to ensure that the macrophage health is equal across all 
EBVs providing more reliable data.  
This experiment was run in vitro and therefore the complex interactions of a 
live host immune system were not observed, this experiment should therefore 
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also be subject to live animal testing in order to test if the outcome is the same 
in and in vivo scenario. 
Due to MAP pathogens being closely related to Mycobacterium bovis 
pathogens, it is recommended that a similar study is set up in order to 
determine if the HIR technology can defend cattle against both Johne’s  
disease and TB. This research could have a significant impact in reducing 
mycobacterial diseases in the UK whilst reducing the cost involved in disease 






7.1 Appendix 1: Cells of the Immune System 
Image downloaded from http://textbookofbacteriology.net/adaptive 2.html on 
the 15 June 2016. Source: Textbook of Bacteriology, 2012 
 
 
7.2 Appendix 2: Laboratory Experiment Data 
 
HH Laboratory Data Set  
(NO release measured in µmol mg) 
All laboratory data sets include a control of 0 which is not represented in the 
tables below: 
 
EBV - 4056 HH
Average
NO Experiment
MAP 40:1 11.604 11.15 11.377
P1C1 4.882 4.475 4.347 4.544 4.562
P2C2 7.836 6.94 7.388
Some materials have been removed due to 3rd party copyright. The 












EBV - 4345 HH
Average
NO Experiment
MAP 40:1 8.175 8.304 8.2395
P1C1 8.526 8.128 8.327
P2C2 10.515 9.392 9.9535
pH Experiment
P1C1 1585 1592 1614 1597
P2C2 1915.4 1699.55 1772.63 1795.86
EBV - 4238 HH
Average
NO Experiment
MAP 40:1 10.819 12.568 11.6935
P1C1 13.185 10.39 11.7875
P2C2 18.089 20.369 19.229
pH Experiment
P1C1 542.33 578.009 590 570.113
P2C2 358.734 409.307 400.786 389.609
EBV - 4212 LL
Average
NO Experiment 
MAP 40:1 9.557 9.197 9.377
P1C1 3.161 3.207 3.184
P2C2 5.614 5.138 5.376
EBV - 4192 LL
Average
NO Experiment
MAP 40:1 8.07 7.075 7.5725
P1C1 7.216 5.625 6.4205
P2C2 12.574 10.924 11.749
pH Experiment
P1C1 2022.19 1701.33 1861.75 1861.76





7.3 Appendix 3: GenStat Analysis 
Genstat 64-bit Release 18.1   
Copyright 2015, VSN International Ltd. 
Registered to: Royal Agricultural University 
 
                 ________________________________________ 
 
                 Genstat Eighteenth Edition 
                 Genstat Procedure Library Release PL26.1 
                 ________________________________________ 
 
 
Nitric Oxide Release Experiment 
 
 
Two-way Analysis of Variance  
 
Some materials have been removed due to 3rd party copyright. The unabridged 
version can be viewed in Lancester Library - Coventry University.
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Some materials have been removed due to 3rd party copyright. The unabridged version 
can be viewed in Lancester Library - Coventry University.
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Some materials have been removed due to 3rd party copyright. The unabridged 
version can be viewed in Lancester Library - Coventry University.
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9  Glossary  
Antibody A blood protein produced in response to and counteracting a 
specific antigen. Antibodies combine chemically with substances 
which the body recognizes as alien, such as bacteria, viruses, 
and foreign substances in the blood 
Antigen  A toxin or other foreign substance which induces an immune 
response in the body, especially the production of antibodies. 
Autoclaved To heat (something) in an autoclave 
Bacilli A rod-shaped bacterium 
Bovine 
Tuberculosis 
Bovine tuberculosis (TB) is a chronic disease of animals caused 
by a bacteria called Mycobacterium bovis, (M.bovis) which is 
closely related to the bacteria that cause human and avian 
tuberculosis. This disease can affect practically all mammals, 
causing a general state of illness, coughing and eventual death. 
Buffy coat The buffy coat is the fraction of an anticoagulated blood sample 
that contains most of the white blood cells and platelets following 
density gradient centrifugation of the blood. 
Cohort A group with a shared characteristic 
Enteric  Relating to or occurring in the intestines 
Histopaque A solution containing polysucrose and sodium diatrizoate, 
adjusted to a density of 1.077 g/mL. This medium facilitates the 
recovery of large numbers of viable mononuclear cells 
in vitro (Of a process) performed or taking place in a test tube, culture 
dish, or elsewhere outside a living organism. 
Lymphoid Relating to or denoting the tissue responsible for producing 
lymphocytes and antibodies. This tissue occurs in the lymph 
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Moxi Z is the only automated cell counter that combines the 
Coulter Principle typically used in high-end cell counters with a 
patented thin-film sensor technology to allow for highly accurate 
(> 95%) and repeatable particle counting and sizing for a broad 
range of cell types 
Pathogen A bacterium, virus, or other microorganism that can cause 
disease 
Phagocytic A cell, such as a white blood cell, that engulfs and absorbs waste 
material, harmful microorganisms, or other foreign bodies in the 
bloodstream and tissues. 
Proliferation Rapid reproduction of a cell, part, or organism. 
Vaccination Vaccination is the administration of antigenic material (a vaccine) 
to stimulate an individual's immune system to develop adaptive 
immunity to a pathogen. Vaccines can prevent or ameliorate 
morbidity from infection. 
Vacutainer A Vacutainer blood collection tube is a sterile glass or plastic tube 
with a closure that is evacuated to create a vacuum inside the 
tube facilitating the draw of a predetermined volume of liquid. 
Zoonotic A zoonotic disease is a disease that can be spread between 
animals and humans. Zoonotic diseases can be caused by 
viruses, bacteria, parasites, and fungi. These diseases are very 
common. 
 
 
 
